These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37492490)

  • 61. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 62. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
    Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.
    Adir Y; Hakrush O; Shteinberg M; Schneer S; Agusti A
    ERJ Open Res; 2018 Jul; 4(3):. PubMed ID: 30083552
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Relationship Between Cough Reflex Sensitivity and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease.
    Cho PSP; Fletcher HV; Turner RD; Patel IS; Jolley CJ; Birring SS
    Lung; 2020 Aug; 198(4):617-628. PubMed ID: 32561993
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD.
    Tagaya E; Yagi O; Sato A; Arimura K; Takeyama K; Kondo M; Tamaoki J
    Pulm Pharmacol Ther; 2016 Aug; 39():81-4. PubMed ID: 27350218
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR; Zhou S; Shaikh A; Willey VJ
    J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
    [No Abstract]   [Full Text] [Related]  

  • 69. Evaluation of Exacerbation and Symptom-Free Time in Patients with COPD.
    de Vries MI; Effing TW; van der Palen J; Schrijver J; van der Valk P; Lenferink A
    COPD; 2023 Dec; 20(1):9-17. PubMed ID: 37552476
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population.
    Marott JL; Çolak Y; Ingebrigtsen TS; Vestbo J; Nordestgaard BG; Lange P
    Respir Med; 2022 Feb; 192():106725. PubMed ID: 34972025
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Coding of COPD Exacerbations and the Implications on Clinical Practice, Audit and Research.
    Echevarria C; Steer J; Bourke SC
    COPD; 2020 Dec; 17(6):706-710. PubMed ID: 33169617
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease.
    Zvizdic F; Begic E; Mujakovic A; Hodzic E; Prnjavorac B; Bedak O; Custovic F; Bradaric H; Durak-Nalbantic A
    Med Arch; 2019 Apr; 73(2):72-75. PubMed ID: 31391690
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study.
    Esteban C; Arostegui I; Garcia-Gutierrez S; Gonzalez N; Lafuente I; Bare M; Fernandez de Larrea N; Rivas F; Quintana JM;
    Respir Res; 2015 Dec; 16():151. PubMed ID: 26695935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monitoring peak expiratory flow could predict COPD exacerbations: A prospective observational study.
    Cen J; Ma H; Chen Z; Weng L; Deng Z
    Respir Med; 2019 Mar; 148():43-48. PubMed ID: 30827473
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease.
    Kocks JW; van den Berg JW; Kerstjens HA; Uil SM; Vonk JM; de Jong YP; Tsiligianni IG; van der Molen T
    Int J Chron Obstruct Pulmon Dis; 2013; 8():273-86. PubMed ID: 23766644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Utilizing an Artificial Neural Network to Predict Self-Management in Patients With Chronic Obstructive Pulmonary Disease: An Exploratory Analysis.
    Bugajski A; Lengerich A; Koerner R; Szalacha L
    J Nurs Scholarsh; 2021 Jan; 53(1):16-24. PubMed ID: 33348455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Telemedicine-based treatment versus hospitalization in patients with severe chronic obstructive pulmonary disease and exacerbation: effect on cognitive function. A randomized clinical trial.
    Schou L; Østergaard B; Rasmussen LS; Rydahl-Hansen S; Jakobsen AS; Emme C; Phanareth K
    Telemed J E Health; 2014 Jul; 20(7):640-6. PubMed ID: 24820535
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study.
    Rodriguez Hermosa JL; Fuster Gomila A; Puente Maestu L; Amado Diago CA; Callejas González FJ; Malo De Molina Ruiz R; Fuentes Ferrer ME; Álvarez Sala-Walther JL; Calle Rubio M
    JMIR Mhealth Uhealth; 2020 Mar; 8(3):e15699. PubMed ID: 32191213
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of pectoralis muscle area on computed tomography with airflow limitation severity and respiratory outcomes in COPD: A population-based prospective cohort study.
    Zhou K; Wu F; Zhao N; Zheng Y; Deng Z; Yang H; Wen X; Xiao S; Yang C; Chen S; Zhou Y; Ran P;
    Pulmonology; 2023 Mar; ():. PubMed ID: 36907812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.